Oxytocin Study for Women Having Their Second or Later Baby
Part of Women’s health & pregnancy clinical trials.
This trial tests oxytocin, a drug used to start or strengthen labor, in women who have given birth before and are being induced with a full-term, single baby. It aims to find the best way to use oxytocin safely and effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have given birth at least once before.
- You are pregnant with only one baby (singleton).
- You are at least 37 weeks and 0 days pregnant.
- Your baby is in a head-down position (vertex).
- You have not had a C-section before and have no reason that prevents a vaginal birth.
- You are not already in active labor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how oxytocin, a medication that helps labor contractions, affects the second stage of labor. It may help researchers understand what leads to safer and smoother delivery for first-time mothers.
This study looks at when oxytocin is started during the pushing phase of labor to understand if timing affects outcomes for the mother and baby.
This study tests whether adding papaverine, a smooth-muscle relaxant, to the standard labor-inducing drug oxytocin can make labor quicker and safer. It is for first-time mothers carrying a single baby head-down who need to start labor with oxytocin.
This trial tests whether taking a break from oxytocin (a medicine used to strengthen contractions) can help reduce the chance of needing a C-section. It is for women whose labor has slowed down despite oxytocin.
This study compares two doses of oxytocin (a medicine given during cesarean section to prevent heavy bleeding) to see which works better for women with high-risk pregnancies. If you are having a planned cesarean and have certain risk factors, this trial may help find the best dose for you.
This trial compares giving oxytocin as a single injection versus a slow drip during C-sections in people at high risk for heavy bleeding after delivery. The goal is to find which method works better to prevent postpartum hemorrhage.
Hear when a new Pregnancy Related trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.